<code id='4CAEB98CB2'></code><style id='4CAEB98CB2'></style>
    • <acronym id='4CAEB98CB2'></acronym>
      <center id='4CAEB98CB2'><center id='4CAEB98CB2'><tfoot id='4CAEB98CB2'></tfoot></center><abbr id='4CAEB98CB2'><dir id='4CAEB98CB2'><tfoot id='4CAEB98CB2'></tfoot><noframes id='4CAEB98CB2'>

    • <optgroup id='4CAEB98CB2'><strike id='4CAEB98CB2'><sup id='4CAEB98CB2'></sup></strike><code id='4CAEB98CB2'></code></optgroup>
        1. <b id='4CAEB98CB2'><label id='4CAEB98CB2'><select id='4CAEB98CB2'><dt id='4CAEB98CB2'><span id='4CAEB98CB2'></span></dt></select></label></b><u id='4CAEB98CB2'></u>
          <i id='4CAEB98CB2'><strike id='4CAEB98CB2'><tt id='4CAEB98CB2'><pre id='4CAEB98CB2'></pre></tt></strike></i>

          
          WSS
          A scientist working at SQZ Biotechnologies in Watertown's Arsenal Yards. -- biotech coverage from STAT
          A scientist working at SQZ Biotechnologies in Watertown, Mass. David L Ryan/Globe Staff

          Next stop: Beacon Hill.

          Governor Maura Healey’s long-awaited plan to double down on state funding for the biotech and medical technology sector came into focus Thursday with the announcement she’ll seek $1 billion over the next decade to reauthorize the state’s 16-year-old life sciences initiative.

          advertisement

          But lawmakers so far are noncommittal on funding the plan. The proposal — dubbed “Life Sciences 3.0″ — is part of a larger economic development bill the Healey administration is expected to file soon. Several expressed support for an industry in which Massachusetts is a leader, but also noted the spending request comes at a time of competing priorities.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          Leave your comment

          Please enter your name
          Please enter your comment

          entertainment